CEL-SCI Corp (CVM)

US · Healthcare · Biotechnology

$1.79+2.87%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-5.7M

EPS

$-0.47

Market cap

$30.8M

Forward P/E

23.0

P/B

2.39

Book value

$0.62

EPS (TTM)

$-1.62

52-week high

$10.16

52-week low

$0.89

50-day MA

$1.67

200-day MA

$2.78

Beta

0.59

Analysts rate CEL-SCI Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.50.

Insiders

3.72%

Institutions

14.63%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CEL-SCI Corp — free to start.

Data updated 2026-10-19.